Business OpportunitiesUnichem Labs gets USFDA nod for hypertension tablets
Pharma firm Unichem Laboratories today said it has received US regulatory approval for Clonidine Hydrochloride tablets USP used in the treatment of hypertension.
- Ranbaxy receives final USFDA approval for Glycopyrolate - India to export fresh litchi to US for first time - After mangoes, India to export litchis to US - Ranbaxy, Aurobindo get USFDA nod for migraine drug - Sun Pharma settles patent dispute with Astra Zeneca - Daiichi wins court battle against Mylan, Matrix
The company has received Abbreviated New Drug Application (ANDA) approval from the United States Food and Drug Administration (USFDA)for the tablets, Unichem Laboratories said in a filing to the BSE.
The tablets are in the strength of 0.1mg, 0.2mg and 0.3mg.